Department of Retina-vitreous and Uveitis, Ophthalmology, Apollo Hospitals, Hyderabad, India.
Uveitis Service, LV Prasad Eye Institute, Hyderabad, India.
Ocul Immunol Inflamm. 2021 May 19;29(4):753-757. doi: 10.1080/09273948.2021.1957123. Epub 2021 Aug 3.
: To report a case of bilateral choroiditis following COVID-19 vaccination.: Case report.: A 34-year old male presented with visual loss one week after the second dose of COVID-19 vaccine. Examination showed large serous detachment of the macula in the right eye and severe choroidal thickening noted on ultrasonography in both eyes. The patient's condition improved rapidly with oral corticosteroids with significant resolution of the serous detachments within two weeks of initiating treatment and complete visual recovery subsequently.: The onset of ocular symptoms starting within one week following vaccination suggests an inflammatory or autoimmune response to the vaccine. Ophthalmologists should consider the option of autoimmune and other inflammatory ocular problems, which may manifest as uveitis, following COVID-19 vaccination. Timely diagnosis and treatment with corticosteroids can result in good visual and structural outcome.
报告 1 例 COVID-19 疫苗接种后双侧脉络膜炎。
病例报告。
1 例 34 岁男性，在 COVID-19 疫苗接种后第 2 剂后 1 周出现视力丧失。检查显示右眼黄斑区有大的浆液性脱离，双眼超声检查均发现严重的脉络膜增厚。患者在开始治疗的 2 周内，眼部症状迅速改善，口服皮质类固醇治疗后，浆液性脱离显著消退，随后视力完全恢复。
眼部症状在接种疫苗后 1 周内出现，提示对疫苗的炎症或自身免疫反应。接种 COVID-19 疫苗后，眼科医生应考虑自身免疫性和其他炎症性眼部问题的可能性，这些问题可能表现为葡萄膜炎。及时诊断和皮质类固醇治疗可获得良好的视力和结构结果。
